BANDIRMA, Turkey (Interstat) — Bandirmaspor delivered a commanding performance at home on Saturday, defeating Buyuksehir BESK 2-0 in a TFF First League match at Bandırma 17 Eylül Stadium.

The victory in Week 34 of Turkey’s second-tier competition solidified a mid-table position for Bandirmaspor, which improved its league record to 13 wins, 12 losses and five draws. The loss left Buyuksehir BESK, a club from Ankara, with a record of two wins, three losses and one draw in the league this season.

Bandirmaspor controlled the match from the outset and broke through in the 39th minute. Midfielder Levent Ayçiçek, a German-born playmaker, provided the service for striker Ivan Šaponjić. The Serbian forward, standing 6-foot-2, finished the chance to give the hosts a 1-0 lead.

The home side doubled its advantage in the 58th minute. Substitute Kerim Avcı, who had entered the match at halftime, recorded an assist just 12 minutes later. His pass found midfielder Caner Hüseyin Bağ, who scored to secure the 2-0 final margin.

Buyuksehir BESK struggled to generate consistent offense against a disciplined Bandirmaspor defense. The visitors’ top performer was attacker Eren Tozlu, who played the full 90 minutes but was unable to influence the scoreline. He received a yellow card in second-half stoppage time.

The match was a physical affair, with 12 yellow cards issued by the officiating crew. Bandirmaspor’s Oğuz Kağan Güçtekin was booked in the 23rd minute, while Buyuksehir BESK saw four players cautioned, including Hasan Batuhan Artarslan and Fırat Şaşi in first-half stoppage time.

The result defied the pregame projection from Interstat’s game simulator, which had predicted a 1-0 victory for Buyuksehir BESK. However, the statistical service’s ELO rating system had heavily favored Bandirmaspor, assigning the home side a 78.4% probability to win.

Bandirmaspor will look to build on the win with a quick turnaround, scheduled to play at Altınordu on Saturday, Feb. 7, 2026. Buyuksehir BESK will aim to regroup after a performance that saw it fail to capitalize on opportunities and succumb to a more clinical opponent on the road.